Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 03 Sept 2026 for Apogee Therapeutics, Inc., €160k. Read the official filing
Filing timeline
BuySaleCarl Dambkowski
Insider track record
Disclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carl Dambkowski: trading record in brief
Filings by Carl Dambkowski span 2 companies, the busiest being Apogee Therapeutics, Inc. and Oruka Therapeutics, Inc. We count 42 filings; the first trade dates from 3 July 2024 and the latest from 3 September 2026.
Sales make up the whole of the open-market record (22 sales, €9.2M). The totals do not cover 2 filings with an undisclosed amount. Other entries cover 16 option exercises. In 2026 alone, the filings show no purchases and 10 sales.
Most recently, on 3 September 2026, the filings show a transaction worth €160k in Apogee Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carl Dambkowski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations42 total
1,375 shares@ US$135.06Common StockSEC:0001140361-26-035613:0
167,123 sharesCommon StockSEC:0001140361-26-035613:1
5,500 shares@ US$134.170.0073% mcap12.9% of flowCommon StockSEC:0001104659-26-092838:1
4,125 shares@ US$22.860.0009% mcap1.7% of flowCommon StockSEC:0001104659-26-092838:0
8,000 shares0Common StockSEC:0001104659-26-084344:0
4,125 sharesCommon StockSEC:0001104659-26-080477:0
5,500 sharesCommon StockSEC:0001104659-26-080477:1
26,400 sharesCommon StockSEC:0001104659-26-077427:0
4,125 shares@ US$22.860.0008% mcap4.1% of flowCommon StockSEC:0001104659-26-071076:0
5,500 shares@ US$78.710.0037% mcap18.6% of flowCommon StockSEC:0001104659-26-071076:1
11,904 shares@ US$7.800.0013% mcap1.4% of flowCommon StockSEC:0000907654-26-000043:1
38,318 shares@ US$58.42670.031% mcap33.5% of flowCommon StockSEC:0000907654-26-000043:3
53,447 shares@ US$59.10360.044% mcap47.2% of flowCommon StockSEC:0000907654-26-000043:4
13,235 shares@ US$59.96690.011% mcap11.9% of flowCommon StockSEC:0000907654-26-000043:5
38,689 shares@ US$6.840.0037% mcap4.0% of flowCommon StockSEC:0000907654-26-000043:0
11,667 shares@ US$11.770.0019% mcap2.1% of flowCommon StockSEC:0000907654-26-000043:2
4,125 shares@ US$22.863.3% of flowCommon StockSEC:0001104659-26-039709:0
2,698 shares@ US$84.317.9% of flowCommon StockSEC:0001104659-26-039709:1
2,702 shares@ US$85.338.0% of flowCommon StockSEC:0001104659-26-039709:2
100 shares@ US$85.890.3% of flowCommon StockSEC:0001104659-26-039709:3
4,125 shares@ US$22.861.9% of flowCommon StockSEC:0001104659-26-024831:0
4,125 shares@ US$22.861.9% of flowCommon StockSEC:0001104659-26-010454:0
116,483 shares0Common StockSEC:0000907654-26-000013:0
14,025 shares@ US$22.866.5% of flowCommon StockSEC:0001104659-26-002574:0
10,900 shares@ US$75.0018.5% of flowCommon StockSEC:0001104659-25-118986:0
25 of 42 declarations
